Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907 in Combination With Escitalopram in Treatment Resistant Depression

NCT00070694 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT00070694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00070694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907 in Combination With Escitalopram in Treatment Resistant Depression
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2003
Completion date
October 31, 2004
Enrollment
96
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder